Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Surgical Endoscopy|March 3, 2022
SAGES 2022 guidelines regarding the use of laparoscopy in the era of COVID-19Amelia T Collings, D Rohan Jeyarajah, Nader M Hanna, et al.
FEMS Microbiology Letters|October 16, 1999
Inhibition of IMP-1 metallo-beta-lactamase and sensitization of IMP-1-producing bacteria by thioester derivativesG G Hammond, J L Huber, M L Greenlee, et al.
Journal of Electrocardiology|January 1, 1997
Admission prediction of expected final myocardial infarct size using weighted ST-segment, Q wave, and T wave measurementsM L Wilkins, C Maynard, B H Annex, et al.
Surgical Endoscopy|February 10, 2021
SAGES guidelines for the use of peroral endoscopic myotomy (POEM) for the treatment of achalasiaGeoffrey P Kohn, Rebecca C Dirks, Mohammed T Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitorsJennifer E Kowalchick, Barbara Leiting, KellyAnn D Pryor, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2007
Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: close analogs of JANUVIA (sitagliptin phosphate)Dooseop Kim, Jennifer E Kowalchick, Scott D Edmondson, et al.
Proteomics|June 3, 2010
Peptidomic profiling of human cerebrospinal fluid identifies YPRPIHPA as a novel substrate for prolylcarboxypeptidaseXuemei Zhao, Katie Southwick, Helene L Cardasis, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|June 3, 2010
Expression, purification and crystallization of human prolylcarboxypeptidasePravien D Abeywickrema, Sangita B Patel, Noel J Byrne, et al.
Pageof 18